cagrilintide and semaglutide New in the August 14, 2025, issue of NEJM: ⁣ ⁣ Cagrilintide–Semaglutide for Overweight or Obesity (REDEFINE 1 phase 3a trial)⁣ ⁣ Cagrilintide– for Overweight Diabetes (REDEFINE 2 phase 3a trial)⁣ ⁣ Buy CagriSema online | Doctoronline

Neuroscience 122:10731080

Understanding your peptide pathway genetics allows you and your provider to weigh berberine's gentler, slower metabolic effects against GLP-1 agonism's rapid appetite and insulin regulation

While the study was observational (meaning that causality cant be confirmed), it does add to the growing body of evidence suggesting that its worth investigating these weight-loss drugs as potential cancer prevention tools, says lead author, Professor Elizabeth McDonald

Researchers must trust vendor claims or invest in expensive independent testing

A., Hossain, M

The results came even faster than what I read online about people getting GLP-1 injections at medical facilities